P

PMG Research, Inc | PMG Research of Charleston

Research site
(Unclaimed)
Location
180 Wingo Way, Suite 203, Mount Pleasant, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Naproxen
Tolterodine
Fesoterodine
BLU-5937
Finerenone
Bempedoic Acid
Bupropion
Azelaic acid
CD5024
Pimodivir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 26 total trials

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiov...

Active, not recruiting
Heart Failure
Other: Placebo
Drug: Finerenone (BAY94-8862)

Trial sponsors

Pfizer logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
AbbVie logo
A
Bavarian Nordic logo
Bayer logo
B
Esperion Therapeutics logo
Ferring logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems